FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2402162362> ?p ?o ?g. }

• W2402162362 endingPage "293" @default.
• W2402162362 startingPage "293" @default.
• W2402162362 abstract "Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study Michael E Crawford,1 Peter Bo Poulsen,2 Berit Schiøttz-Christensen,3 Andreas Habicht,4 Mette Strand,2 Flemming W Bach5 1Copenhagen City Pain Clinic, Copenhagen K, 2Pfizer Denmark ApS, Ballerup, 3Spine Center Southern Denmark, Lillebælt Hospital, Middelfart, 4Signifikans ApS, Vedbæk, 5Department of Neurology, Aalborg University Hospital, Aalborg, Denmark Objective: The aim of this study was to provide evidence regarding the real-life efficacy of pregabalin in the treatment of peripheral neuropathic pain (NeP) in Denmark. Methods: In this prospective, observational, noninterventional study, pregabalin (Lyrica®) was prescribed following usual clinical practice. Compared with baseline, the primary study end points after 3 months of observation were changes in 1) the average level of pain during the past week, 2) the worst level of pain during the past week, and 3) the least level of pain during the past week. The Wilcoxon signed-rank test was used to perform paired analyses, and a multivariate regression analysis investigated factors driving change in pain. Results: A total of 86 of the 128 patients included were regarded as efficacy evaluable (those completing 3 months of pregabalin treatment). Patients (59 years) were long-time sufferers of peripheral NeP, and 38% of them had comorbidities. The majority had previously been treated with tricyclic antidepressants or gabapentin. The average dose of pregabalin was 81.5 mg/d at baseline and 240 mg/d after 3 months. A clinically and statistically significant improvement of 2.2 points in the average level of pain intensity was found after 3 months. The higher the pain intensity at baseline, the higher was the reduction of the pain score. Positive results were also found for pain-related sleep interference, patients’ global impression of change, quality of life, and work and productivity impairment. Twenty-one patients reported 28 adverse events. Conclusion: This real-life study indicates that for some patients (two-thirds), addition of pregabalin for peripheral NeP helps to reduce their pain intensity significantly. Keywords: noninterventional study, pain intensity, usual clinical practice, sleep interference and quality of life" @default.
• W2402162362 created "2016-06-24" @default.
• W2402162362 creator A5001666840 @default.
• W2402162362 creator A5014762636 @default.
• W2402162362 creator A5023361211 @default.
• W2402162362 creator A5026741798 @default.
• W2402162362 creator A5052114763 @default.
• W2402162362 creator A5086045688 @default.
• W2402162362 date "2016-05-01" @default.
• W2402162362 modified "2023-09-25" @default.
• W2402162362 title "Real-life efficacy of pregabalin for the treatment of peripheral neuropathic pain in daily clinical practice in Denmark: the NEP-TUNE study" @default.
• W2402162362 cites W1792140355 @default.
• W2402162362 cites W1981451826 @default.
• W2402162362 cites W1991179454 @default.
• W2402162362 cites W1991480414 @default.
• W2402162362 cites W2061668392 @default.
• W2402162362 cites W2063957311 @default.
• W2402162362 cites W2073050255 @default.
• W2402162362 cites W2086325363 @default.
• W2402162362 cites W2097358174 @default.
• W2402162362 cites W2117284502 @default.
• W2402162362 cites W2128412489 @default.
• W2402162362 cites W2131229172 @default.
• W2402162362 cites W2133198130 @default.
• W2402162362 cites W2134947331 @default.
• W2402162362 cites W2136415182 @default.
• W2402162362 cites W2181166701 @default.
• W2402162362 cites W2473786944 @default.
• W2402162362 doi "https://doi.org/10.2147/jpr.s102744" @default.
• W2402162362 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4881924" @default.
• W2402162362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27284265" @default.
• W2402162362 hasPublicationYear "2016" @default.
• W2402162362 type Work @default.
• W2402162362 sameAs 2402162362 @default.
• W2402162362 citedByCount "1" @default.
• W2402162362 countsByYear W24021623622020 @default.
• W2402162362 crossrefType "journal-article" @default.
• W2402162362 hasAuthorship W2402162362A5001666840 @default.
• W2402162362 hasAuthorship W2402162362A5014762636 @default.
• W2402162362 hasAuthorship W2402162362A5023361211 @default.
• W2402162362 hasAuthorship W2402162362A5026741798 @default.
• W2402162362 hasAuthorship W2402162362A5052114763 @default.
• W2402162362 hasAuthorship W2402162362A5086045688 @default.
• W2402162362 hasBestOaLocation W24021623621 @default.
• W2402162362 hasConcept C126322002 @default.
• W2402162362 hasConcept C142724271 @default.
• W2402162362 hasConcept C1862650 @default.
• W2402162362 hasConcept C204787440 @default.
• W2402162362 hasConcept C2776468701 @default.
• W2402162362 hasConcept C2776608144 @default.
• W2402162362 hasConcept C2777107010 @default.
• W2402162362 hasConcept C2780052408 @default.
• W2402162362 hasConcept C2780764818 @default.
• W2402162362 hasConcept C2781118164 @default.
• W2402162362 hasConcept C42219234 @default.
• W2402162362 hasConcept C71924100 @default.
• W2402162362 hasConceptScore W2402162362C126322002 @default.
• W2402162362 hasConceptScore W2402162362C142724271 @default.
• W2402162362 hasConceptScore W2402162362C1862650 @default.
• W2402162362 hasConceptScore W2402162362C204787440 @default.
• W2402162362 hasConceptScore W2402162362C2776468701 @default.
• W2402162362 hasConceptScore W2402162362C2776608144 @default.
• W2402162362 hasConceptScore W2402162362C2777107010 @default.
• W2402162362 hasConceptScore W2402162362C2780052408 @default.
• W2402162362 hasConceptScore W2402162362C2780764818 @default.
• W2402162362 hasConceptScore W2402162362C2781118164 @default.
• W2402162362 hasConceptScore W2402162362C42219234 @default.
• W2402162362 hasConceptScore W2402162362C71924100 @default.
• W2402162362 hasLocation W24021623621 @default.
• W2402162362 hasLocation W24021623622 @default.
• W2402162362 hasLocation W24021623623 @default.
• W2402162362 hasLocation W24021623624 @default.
• W2402162362 hasLocation W24021623625 @default.
• W2402162362 hasLocation W24021623626 @default.
• W2402162362 hasOpenAccess W2402162362 @default.
• W2402162362 hasPrimaryLocation W24021623621 @default.
• W2402162362 hasRelatedWork W1605129038 @default.
• W2402162362 hasRelatedWork W1981451826 @default.
• W2402162362 hasRelatedWork W2014185462 @default.
• W2402162362 hasRelatedWork W2068055112 @default.
• W2402162362 hasRelatedWork W2080027527 @default.
• W2402162362 hasRelatedWork W2324402108 @default.
• W2402162362 hasRelatedWork W2811479631 @default.
• W2402162362 hasRelatedWork W2896769073 @default.
• W2402162362 hasRelatedWork W2994632038 @default.
• W2402162362 hasRelatedWork W4309261544 @default.
• W2402162362 isParatext "false" @default.
• W2402162362 isRetracted "false" @default.
• W2402162362 magId "2402162362" @default.
• W2402162362 workType "article" @default.